About Santhera Pharmaceuticals

Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focusing on the development and marketing of innovative pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases. This area of high unmet medical need includes many orphan and niche indications with no current therapy.

Company Highlights
Year Founded

2004

icon-altEmployees

90

Location (HQ)

CHE

Since Last Funding

1 year 8 months

Monthly Website Visitors

22.9K

icon-altTotal Investment Amt

$200M

Last Funding Round

Post Ipo Debt

icon-altMoM Headcount Growth

3.44%

icon-altYoY Headcount Growth

38.4%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Pharmaceutical

Biotechnology

Pharmaceutical Manufacturing

Pharmaceuticals